Document is current
Any future updates will be listed below
-
Authors
Le Hars, Matthieu
Joussain, Charles
Jégu, Teddy
Epstein, Alberto L. https://orcid.org/0000-0002-4322-1511
- License Information
-
More Information
Article History
Received: 31 July 2024
Revised: 22 October 2024
Accepted: 31 October 2024
First Online: 12 November 2024
Competing interests
: ALE, TJ, and CJ are shareholders of EG 427. ALE is the chief scientific officer (CSO) of EG 427 while TJ is the director of the R&D platform of EG 427. ALE and TJ are co-inventors on patents related to the use of replication-incompetent herpes simplex virus-based vectors, owned by the University of Versailles Saint Quentin (France) and EG 427.
